Lupin rises on receiving US FDA approval for Generic Lumigan Ophthalmic solution

24 Feb 2015 Evaluate

Lupin is currently trading at Rs. 1654.80, up by 6.10 points or 0.37% from its previous closing of Rs. 1648.70 on the BSE.

The scrip opened at Rs. 1646.05 and has touched a high and low of Rs. 1667.30 and Rs. 1626.00 respectively. So far 26829 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1705.60 on 19-Feb-2015 and a 52 week low of Rs. 903.95 on 27-May-2014.

Last one week high and low of the scrip stood at Rs. 1705.60 and Rs. 1604.40 respectively. The current market cap of the company is Rs. 74369.04 crore.

The promoters holding in the company stood at 46.66%, while Institutions and Non-Institutions held 42.51% and 10.83% respectively.

Lupin has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc (LPI), the company's US subsidiary would commence marketing the product shortly. 

Lupin's Bimatoprost Ophthalmic Solution, 0.03% is the AT rated generic equivalent of Lumigan Ophthalmic Solution, 0.03% and is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Lupin's Bimatoprost Ophthalmic Solution, 0.03% filing was made from its Indore facility which was audited in January, 2015. Two Lupin facilities, the Lupin Bioresearch Center, Pune (LBC) and its manufacturing facility at Pithampur, near Indore were audited by the US FDA in November, 2014 and January, 2015 respectively. Both the audits were completed successfully with LBC not receiving any observations and the Indore facility receiving six observations (483's). Since then, the Indore facility has received 1 ANDA approval and 2 site-transfer approvals.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations as well as biotechnology products and APIs globally.

 

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×